CNY 2.39
(-0.42%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -52.03 Million | 112.75 Million | 146.47 Million | -74.36 Million | -89.15 Million | -1.32 Billion |
Net Income | -184.21 Million | -292.81 Million | -375.67 Million | -306.25 Million | 25.77 Million | -61.59 Million |
Depreciation & Amortization | 2.82 Million | 1.85 Million | 5.66 Million | 2.2 Million | 2.46 Million | 2.26 Million |
Deferred income taxes | 245.55 Thousand | -5.72 Million | -6.21 Million | 1.69 Million | -1.14 Million | -4.18 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 16.02 Million | 183.3 Million | 194.63 Million | -10.52 Million | -124.69 Million | -1.21 Billion |
Other non-cash items | 102.71 Million | 220.4 Million | 321.85 Million | 240.2 Million | 7.3 Million | -46.2 Million |
Investing Cash Flow | -539.42 Thousand | 36.05 Million | 143.81 Million | 91.83 Million | -371.12 Million | 308.14 Million |
Investments in PPE | -652.42 Thousand | -545.88 Thousand | -5300.00 | -26.55 Thousand | -2.28 Million | -9.42 Million |
Acquisitions | 113 Thousand | 36.4 Million | 130 Million | -48.87 Million | 1.22 Million | -2.28 Million |
Investment purchases | - | -10 Thousand | -15 Thousand | 1.02 Million | -618 Million | -709.34 Million |
Sales/Maturities of investments | - | 204.05 Thousand | 154.58 Thousand | 139.73 Million | 247.92 Million | 995.55 Million |
Other Investing Activities | 113 Thousand | 2760.50 | 13.68 Million | -26.55 Thousand | 14.69 Thousand | 33.65 Million |
Financing Cash Flow | 28.51 Million | -202.87 Million | -313.31 Million | -243.16 Million | 625.19 Million | 581.22 Million |
Debt repayment | -64.56 Million | -44 Million | -13.7 Million | -10 Million | -70 Million | -424.4 Million |
Dividends payments | -40.04 Million | -84.34 Million | -97.96 Million | -179.62 Million | -70.48 Million | -6.02 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -36.04 Million | -74.52 Million | -201.65 Million | -53.53 Million | 765.68 Million | 587.24 Million |
Accounts receivables | 308.39 Thousand | -1.49 Million | 157.23 Million | 36.33 Million | -152.34 Million | 269.68 Million |
Accounts payables | 31.24 Million | 4.74 Million | -376.65 Million | 101.16 Million | 524.3 Million | 330.84 Million |
Inventory | -15.53 Million | 185.78 Million | 420.26 Million | -149.72 Million | -495.5 Million | -1.81 Billion |
Other working capital | 31.49 Million | -5.72 Million | -6.21 Million | 1.69 Million | -1.14 Million | 596.34 Million |
Cash at beginning of period | 61.68 Million | 90.51 Million | 113.58 Million | 339.51 Million | 174.37 Million | 607.86 Million |
Cash at end of period | 35.08 Million | 36.45 Million | 90.51 Million | 113.58 Million | 339.51 Million | 174.37 Million |
Capital Expenditure | -652.42 Thousand | -545.88 Thousand | -5300.00 | -26.55 Thousand | -2.28 Million | -9.42 Million |
Effect of forex changes on cash | 2087.95 | 11.62 Thousand | -40.32 Thousand | -226.72 Thousand | 212.82 Thousand | 2.16 Million |
Net cash flow / Change in cash | -26.59 Million | -54.06 Million | -23.07 Million | -225.92 Million | 165.13 Million | -433.48 Million |
Free Cash Flow | -52.68 Million | 112.2 Million | 146.46 Million | -74.39 Million | -91.43 Million | -1.33 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -41.25 Million | -33.48 Million | -184.21 Million | -112.19 Million | -22.35 Million | -24.02 Million |
Depreciation & Amortization | 617.1 Thousand | 617.1 Thousand | 2.82 Million | 674.08 Thousand | -1.3 Million | 736 Thousand |
Deferred income taxes | - | - | 245.55 Thousand | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 264.93 Million | - | 16.02 Million | -15.22 Million | 12.45 Million | -12.45 Million |
Other non-cash items | 48.43 Million | 51.2 Million | 102.71 Million | 107.28 Million | 4.99 Million | 21.18 Million |
Investing Cash Flow | -4022.15 | 4 Million | -539.42 Thousand | - | 48.03 Thousand | -567.17 Thousand |
Investments in PPE | -4022.15 | - | -652.42 Thousand | - | -14.96 Thousand | -567.17 Thousand |
Acquisitions | - | 4000.00 | 113 Thousand | - | 63 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | 4 Million | - | - | - | - |
Other Investing Activities | -4022.15 | 4 Million | 113 Thousand | - | -0.52 | - |
Financing Cash Flow | -3.51 Million | 114.4 Thousand | 28.51 Million | 4.07 Million | 9.01 Million | 9.98 Million |
Debt repayment | - | - | -64.56 Million | -64.56 Million | - | - |
Dividends payments | -7.97 Million | -2.53 Million | -40.04 Million | -8.18 Million | -8.22 Million | -15.86 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.8 Million | 114.4 Thousand | -36.04 Million | -60.48 Million | 17.23 Million | 25.84 Million |
Accounts receivables | -2.46 Million | - | 308.39 Thousand | 308.39 Thousand | 776.48 Thousand | -776.48 Thousand |
Accounts payables | - | - | 31.24 Million | - | - | - |
Inventory | 267.39 Million | - | -15.53 Million | -15.53 Million | 11.67 Million | -11.67 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 54.62 Million | 35.08 Million | 61.68 Million | 39.47 Million | 11.06 Million | 16.18 Million |
Cash at end of period | 57.45 Million | 54.62 Million | 35.08 Million | 35.08 Million | 13.9 Million | 11.06 Million |
Capital Expenditure | -4022.15 | - | -652.42 Thousand | - | -14.96 Thousand | -567.17 Thousand |
Effect of forex changes on cash | 306.19 | 79.99 | 2087.95 | -827.61 | -673.59 | 5626.85 |
Net cash flow / Change in cash | 2.83 Million | 19.53 Million | -26.59 Million | -4.38 Million | 2.83 Million | -5.12 Million |
Free Cash Flow | 6.56 Million | 17.72 Million | -52.68 Million | -5.57 Million | -6.24 Million | -15.11 Million |
002330
8804
4047
BMO
HCG
BBY